Apellis Pharmaceuticals Inc ROIC
Quel est le ROIC de Apellis Pharmaceuticals Inc?
Le ROIC de Apellis Pharmaceuticals Inc est -64.16%
Quelle est la définition de ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC des entreprises dans Health Care secteur sur NASDAQ par rapport à Apellis Pharmaceuticals Inc
Que fait Apellis Pharmaceuticals Inc?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
Entreprises avec roic similaire à Apellis Pharmaceuticals Inc
- Gritstone Bio Inc a ROIC de -64.25%
- POET Technologies a ROIC de -64.23%
- Interconnect Ventures a ROIC de -64.21%
- Marathon Patent a ROIC de -64.18%
- Skeena Resources a ROIC de -64.18%
- Transphorm a ROIC de -64.17%
- Apellis Pharmaceuticals Inc a ROIC de -64.16%
- Professional Diversity Network a ROIC de -64.13%
- Atomo Diagnostics a ROIC de -64.10%
- GeneNews a ROIC de -64.08%
- Dragon Victory International Ltd a ROIC de -64.05%
- OzAurum Resources a ROIC de -64.03%
- STARAMBA SE a ROIC de -64.01%